Drug-inducing gynaecomastia - a critical review

Andrologia

Volumn 44, Issue SUPPL.1, 2012, Pages 621-626

  Krause, W ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

ATC DDD; Drugs; Gynaecomastia; Study quality

Indexed keywords

ALCOHOL; ALLOPURINOL; AMIODARONE; AMPHETAMINE; ANASTROZOLE; ANDROGEN; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; ATORVASTATIN; BEZAFIBRATE; BICALUTAMIDE; BOTULINUM TOXIN; BUMETANIDE; CAPTOPRIL; CENTRAL STIMULANT AGENT; CETIRIZINE; CHLORMADINONE; CIMETIDINE; CIPROFLOXACIN; CLADRIBINE; CLOMIFENE; CYCLOSPORIN; CYPROTERONE ACETATE; DASATINIB; DIURETIC AGENT; ESTROGEN; PROLACTIN; SEX HORMONE; STEROID HORMONE; UNINDEXED DRUG;

ADVERSE OUTCOME; ARTICLE; GYNECOMASTIA; HORMONE METABOLISM; HUMAN;

GYNECOMASTIA; HUMANS; MALE;

EID: 84861486394     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2011.01240.x     Document Type: Article

References (20)

1. Adibelli ZH, Oztekin O, Gunhan-Bilgen I, Postaci H, Uslu A, Ilhan E (2010) Imaging characteristics of male breast disease. Breast J16:510-518.
2. Biglia A, Blanco JL, Martínez E, Domingo P, Casamitjana R, Sambeat M, Milinkovic A, Garcia M, Laguno M, Leon A, Larrousse M, Lonca M, Mallolas J, Gatell JM (2004) Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study. Clin Infect Dis39:1514-1519.
3. Braunstein GD (2007) Clinical practice. Gynecomastia. N Engl J Med357:1229-1237.
4. Calzada L, Torres-Calleja J, Martinez JM, Pedrón N (2001) Measurement of androgen and estrogen receptors in breast tissue from subjects with anabolic steroid-dependent gynecomastia. Life Sci69:1465-1469.
5. Das DK, Junaid TA, Mathews SB, Ajrawin TG, Ahmed MS, Madda JP, Mirza K (1995) Fine needle aspiration cytology diagnosis of male breast lesions. Acta Cytol39:870-876.
6. Dialani V, Baum J, Mehta TS (2010) Sonographic features of gynecomastia. J Ultrasound Med29:539-547.
7. Evidence-Based Medicine Working Group; Guyatt G, Cairns J, Churchill D, Cook D, Haynes B, Hirsh J, Irvine J, Levine M, Levine M, Nishikawa J, Sackett D, Brill-Edwards P, Gerstein H, Gibson J, Jaeschke R, Kerigan A, Neville A, Panju A, Detsky D, Enkin M, Frid P, Gerrity M, Laupacis A, Lawrence V, Menard J, Moyer V, Mulrow C, Links P, Oxman A, Sinclair J, Tugwell P (1992) Evidence-based medicine - a new approach to teaching the practice of medicine. JAMA268:2420-2425.
8. Ferreira M, Mesquita M, Quaresma M, André S (2008) Prolactin receptor expression in gynaecomastia and male breast carcinoma. Histopathology53:56-61.
9. Gimenez-Roqueplo AP, Dupuy M, Delalande O, Visot A, Jedynak CP, Peillon F, Derome PJ (1992) Prolactin microadenoma in men. Study of 14 cases. Ann Med Interne (Paris)143:94-97.
10. Griffin JE, Wilson DJ (2003) Disorders of the testes and the male reproductive tract. In: Williams Textbook of Endocrinology, 10th edn. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds). Elsevier, New York etc., pp 819-875.
11. Iuanow E, Kettler M, Slanetz PJ (2011) Spectrum of disease in the male breast. AJR Am J Roentgenol196:W247-W259.
12. Labhart A, Hedinger C, Kistler G, Müller J (1978) Testis in Labhart Klinik der inneren Sekretion, 3. Auflage, Springer, Berlin, Heidelberg, New York, pp 497-499.
13. Leiber B (1995) Aspekte eines polyatiologischen Symptons Gynakomastie. Gyne16:237-241.
14. Niewoehner CB, Nuttal FQ (1984) Gynecomastia in a hospitalized male population. Am J Med77:633-638.
15. Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BG, Nelson MR (2002) Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis. AIDS16:506-507.
16. Satoh T, Fujita KI, Munakata H, Itoh S, Nakamura K, Kamataki T, Itoh S, Yoshizawa I (2000) Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase. Anal Biochem286:179-186.
17. Satoh T, Munakata H, Fujita K, Itoh S, Itoh S, Kamataki T, Yoshizawa I (2003) Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17. Biol Pharm Bull26:695-700.
18. Satoh T, Tomikawa Y, Takanashi K, Itoh S, Itoh S, Yoshizawa I (2004) Studies on the interactions between drugs and estrogen. III. Inhibitory effects of 29 drugs reported to induce gynecomastia on the glucuronidation of estradiol. Biol Pharm Bull27:1844-1849.
19. Scottish Office (1993) Clinical Resources and Audit Group. Clinical Guidelines: Report by a Working Group. Scottish Office, Edinburgh.
20. Simon BE, Hoffman S, Kahn S (1973) Classification and surgical correction of gynecomastia. Plast Reconstr Surg51:48-52.